Published in Cancer Weekly, December 8th, 2009
"Veran's innovative instrumentation and automatic 4D registration combined with VIDA's highly validated lung analysis and visualization is a true next-generation guided biopsy solution that addresses significant limitations in our current evaluation of patients with suspected lung cancer,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.